Press Releases

Q2 2026 net product revenue of $50.7 million, up 92% year-over-year and 15% sequentially from Q1 2026, marking the eighth consecutive quarter of sequential revenue growth since the commercial launch of ANKTIVA®, driven by continued adoption among U.S. urologists and strong market access First-half 2026 net product revenue of $94.8 million, up 121% compared with the first-half of 2025 In July 2026, we announced the Emirates Drug Establishment of the United Arab Emirates granted the broadest marketing authorization for ANKTIVA across BCG-unresponsive NMIBC for CIS and papillary disease and metastatic NSCLC The FDA accepted for review the Company’s supplemental Biologics License Appl

Q2 2026 Modern Oral Gross Revenue increased 149% to $87.0 million and Net Sales increased 128% to $68.4 million. Accounting for 48% of total company net sales, up from 26% in Q2 2025  Raising FY 2026 Modern Oral Gross and Net Sales guidance Turning Point Brands, Inc. ("TPB" or "the Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, today announced financial results for the second quarter ended June 30, 2026. Q2 2026 Financial Highlights (All results reflect comparisons to prior-year period) Total Consolidated Net Sales increased 22.6% to $142.9 million S

Second quarter GAAP Diluted EPS of $0.45 Adjusted EPS of $1.48 increased 8.8% over the prior year period Revenue increased 29% on a GAAP basis to $3.4 billion, increasing 31% on an adjusted basis and 5.3% on a Pro Forma basis Net cash provided by operating activities was $493 million and Free cash flow1 was $525 million, increasing 220% Updated full-year 2026 outlook, including Adjusted revenue growth of 29 - 30%, Adjusted EBITDA growth of 32 - 34%, Adjusted EPS growth of 7.0 - 8.5% and Free Cash Flow1 growth of 33 - 39%, to $2,150 - $2,250 million2 Updated 2026 outlook for Pro Forma revenue growth to 4.5 - 5.0%, as compared to 5.1 - 5.7% and Pro Forma Adjusted EBITDA growth

Reports strong second quarter results, including net income of $283 million, Adjusted EBITDA(1) of $996 million, excluding one-time transaction-related expenses(2), and Distributable Cash Flow, as adjusted(1), of $608 million Increases full year 2026 Adjusted EBITDA guidance by $400 million to $3.5 billion to $3.7 billion Sunoco LP (NYSE:SUN) ("SUN" or the "Partnership") and SunocoCorp LLC (NYSE:SUNC) ("SUNC") today reported financial and operating results for the quarter ended June 30, 2026. Financial and Operational Highlights Attributable to Sunoco LP Net income for the second quarter of 2026 was $283 million compared to $86 million in the second quarter of 2025. Adjusted EB

Q2 SaaS Revenue Grows to 76% of Total Revenue Q2 SaaS Monthly ARPU Increases 12% Year-Over-Year to $394 Company Announces Strategic Restructuring Plan to Improve Operating Efficiencies Thryv Holdings, Inc. (NASDAQ:THRY) ("Thryv" or the "Company"), the provider of Thryv®, an AI-native growth platform for local service businesses, reported results for the second quarter of 2026. "Our second quarter marked another step forward in the transformation of our business, with SaaS now representing 76% of our revenue and ARPU growing 12% year-over-year," said Joe Walsh, Thryv Chairman and CEO. "Our SaaS profile now reflects our deliberate focus on the newly launched Thryv Growth Platform,

Energy Transfer LP (NYSE:ET) ("Energy Transfer" or the "Partnership") today reported financial results for the quarter ended June 30, 2026. Energy Transfer reported net income attributable to partners for the three months ended June 30, 2026 of $2.09 billion compared to $1.16 billion for the three months ended June 30, 2025. For the three months ended June 30, 2026, net income per common unit (basic) was $0.59. Adjusted EBITDA for the three months ended June 30, 2026 was $5.07 billion compared to $3.87 billion for the three months ended June 30, 2025, an increase of 31%. Distributable Cash Flow attributable to partners, as adjusted, for the three months ended June 30, 2026 was $2.59 b

Advances Fortitude's venture mining strategy and further strengthens its owned power portfolio Acquisition marks latest milestone as Fortitude advances toward public markets through proposed combination with HeartSciences (NASDAQ:HSCS) Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, today announced that it has completed the acquisition of a 12.5 megawatt ("MW") digital infrastructure facility in Prosser, Nebraska (the "Prosser Facility") in an asset purchase of the underlying real property. The transaction was funded entirely with cash on the Company's balance sheet. This press release features multimedia. View the

Record second-quarter revenues of $9.5 billion; GAAP1 Net Income of $932 million, or 9.9% of sales EBITDA2 in the second quarter was 17.5% of sales; Diluted EPS of $6.73 Full-year revenues are expected to range from up 10% to up 13%, an improvement from prior guidance of up 8% to 11% EBITDA is now expected to be in the range of 18.0% to 18.5%, compared to prior guidance of 17.75% to 18.5% The company returned $501 million to shareholders in the second quarter in the form of cash dividends and share repurchases Cummins Inc. (NYSE:CMI) today reported results for the second quarter of 2026. "Cummins delivered record second-quarter results, reflecting robust customer orders fo

Q2 2026 net revenue of $329.5 million, up 6% compared to $311.4 million in Q2 2025. Q2 2026 net income attributable to the Company of $17.4 million, or diluted earnings per share (EPS) of $0.61, up 90% and 97% respectively, compared to net income of $9.2 million, or diluted EPS of $0.31, in the prior year. Adjusted EBITDA of $57.8 million in Q2 2026 and Adjusted EPS per diluted share of $0.82 up 11% and 45% respectively, compared to $51.9 million and $0.57 in Q2 2025. Paid $7.9 million in dividends and invested $11.9 million in capital in the second quarter, continuing the commitment of balanced capital allocation. Albany International Corp. (NYSE:AIN) today reported operating

Venu Holding Corporation ("VENU" or the "Company") (NYSE:VENU), owner, operator, and developer of premium live entertainment destinations, will host a conference call to discuss financial results and strategic initiatives for its fiscal second quarter ended June 30, 2026, on Thursday, August 13 at 11:00 a.m. Eastern Time. The Company will issue a press release reporting its results prior to market opening. Conference Call Details Thursday, August 13, 2026, at 11:00 a.m. Eastern Time North America Toll Free Dial-In Number +1 833-461-5787 International Toll Dial-In Number +1 585-542-9983 Meeting ID 512 667 005 Webcast Link https://

LOUISVILLE, Ky., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ:CREX), a leading provider of digital signage and media solutions, announced today that it will release its financial results for the three months ended June 30, 2026 before the market open on Thursday, August 13, 2026. A conference call to review the results is scheduled for Thursday, August 13, 2026, at 9:00 am Eastern Time, which will include prepared remarks and materials from management followed by a live Q&A. The call will be hosted by Rick Mills, Chairman and Chief Executive Officer, Tamra Koshewa, Chief Financial Officer and George Sautter, Chief Strate

First module of the rolling NDA for QTORIN™ rapamycin for microcystic lymphatic malformations submitted to FDA, with completion of the NDA submission on track for the second half of 2026 Preparing for a planned standalone U.S. commercial launch of QTORIN™ rapamycin for microcystic lymphatic malformations in the first half of 2027, if approved Initiation of Phase 3 trial of QTORIN™ rapamycin for the treatment of cutaneous venous malformations planned for the fourth quarter of 2026 Initiation of Phase 2 trial of QTORIN™ pitavastatin for the treatment of disseminated superficial actinic porokeratosis planned for the second half of 2026 Topline results from the Phase 2 LOTU t

BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases, today announced that members of Zevra’s executive leadership team will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 11:00 a.m. ET. Additionally, management will be available for one-on-one meetings with registered conference attendees. A link to the live webcast will be accessible on the "Events & Presentations" page in the Investor Relations section of Zevra’s website at investors.zevra.com. About Zevra Therape

CLEVELAND, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-On Payment (NTAP) status for ZEVASKYN (prademagene zamikeracel) under the Fiscal Year 2027 Hospital Inpatient Prospective Payment System (IPPS) Final Rule. NTAP status provides supplemental CMS reimbursement above standard hospital payments to support access to innovative therapies like ZEVASKYN. This additional funding is awarded to technologies that meet CMS criteria, including demonstrating substantia

Enabling Consumers to Hold and Spend Dollar Value Across One of the World's Largest Money Movement Networks The Western Union Company ("Western Union") (NYSE:WU) and Rain, today announced the launch of Stablecard by Western Union, a digital wallet and USDPT-backed Visa secured credit card designed to enable consumers to hold, move and spend U.S. dollar value globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804251471/en/ Stablecard offers a consumer-friendly way to receive funds and store value in USDPT, a U.S. dollar stablecoin, in a secure digital wallet and spend seamlessly anywhere Visa is accepted. USDPT is issu

ROCK HILL, S.C., Aug. 04, 2026 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD), a leading provider of additive manufacturing solutions, today announced a leadership transition plan in which Dr. Jeffrey Graves will step down as President and Chief Executive Officer and retire from the Board of Directors. To support a seamless transition, Dr. Graves will continue to serve as President and Chief Executive Officer until a successor is appointed, which is expected to occur later this year. Following his successor’s appointment, Dr. Graves will serve in a consulting capacity for six months to facilitate an effective transition. The Board of Directors has initiated a comprehensive search process to id

OTTAWA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Telesat LEO ULC, a subsidiary of Telesat Corporation (Nasdaq and TSX:TSAT), one of the world’s largest and most innovative satellite operators, today announced that it has signed a $2.3 billion Telesat Lightspeed services contract with Canada’s Defence Investment Agency (DIA) to deliver secure Military Ka-band (Mil-Ka) Arctic connectivity to the Canadian Armed Forces (CAF) under the Enhanced Satellite Communications Project – Polar (ESCP-P) program. The contract also includes two five-year option periods valued at approximately $200 million each, bringing the total contract value to $2.7 billion. All amounts are in Canadian dollars unless otherwise

WAKIX® Net Revenue Grew 30% Year over Year to $261.3 Million for Second Quarter 2026; Estimated Average Patients Increased 450 to 8,950; Reiterates 2026 WAKIX Net Revenue Guidance of $1.0 Billion to $1.04 Billion Phase 1 SAD Data for BP-205 Demonstrate Favorable PK and Safety/Tolerability Profiles; Phase 1 MAD Data Expected in Q4 2026 BP-205 IND Open in US; Initiating Phase 1b Study in Sleep-Deprived Healthy Volunteers in Q3; Data Expected Early 2027 Initiating Phase 2 Trials for BP-205 in Mid-2027 to Evaluate Multiple CNS Indications Pitolisant GR NDA Accepted in July; Target PDUFA Date April 1, 2027 Pitolisant HD On Track for Phase 3 Topline Data in 2027 and Target PDUFA Dat

JUPITER, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ:DYAI) ("Dyadic" or the "Company"), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions across the life sciences, food & nutrition, bioindustrial and biopharmaceutical markets, today announced the expansion of its commercial non-animal dairy pipeline through a new development and commercial license agreement with a European biotechnology company for additional precision-fermented dairy proteins. The agreement further expands Dyadic's growing food and nutrition pipeline while reinforcing the Company's strategy of developing recurring revenue opportunities throu

CHANDLER, Ariz., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Microchip Technology (NASDAQ:MCHP) today announced a demonstration showcasing an end‑to‑end PCIe® Gen 6 storage architecture, combining Microchip’s Switchtec™ PCIe Gen 6 switches with high-performance Micron 9650 NVMe® solid state drives (SSDs). The demonstration highlights the role of next‑generation PCIe technology in enabling higher data throughput, reduced latency and scalable connectivity for AI, high‑performance computing (HPC) and cloud data center workloads. At the 2026 Future of Memory and Storage (FMS) Conference, the demonstration features a Microchip Switchtec Gen 6 PCIe fanout switch acting as a high‑bandwidth, low‑latency in